Omnix Medical bags €10.8m from EIC Accerator FundIsrael’s Omnix Medical has been granted €10.8m needed to start Phase I/II development of a potential AMR breaking drug in Gram-negative bugs. more ➔
Germany orders antibody therapies from USAGermany has become the first country in Europe to buy the US emergency-approved COVID-19 antibody therapies from Regeneron and Eli Lilly. more ➔
Servier and MiNA Therapeutics sign €220m dealFrench Servier SA and the UK’s MiNA Therapeutics Ltd have entered into a R&D partnership to identify and develop small activating RNAs (saRNA) to treat neurological disorders. more ➔
LSP leads €21m round into Neurent MedicalIrish life sciences company Neurent Medical has closed a €21m Series B investment co-led by LSP as well as Atlantic Bridge with participation of Fountain Healthcare Partners. more ➔
Janssen presents one-shot COVID-19 vaccine dataJ&J subsidiary Janssen Pharma has presented updated Phase I/II antibody levels supporting a single shot administration for its COVID-19 vaccine. more ➔
German researchers find reason for remdesivir’s inefficiencyGerman Researchers have unraveled how remdesivir interferes with the viral RNA polymerase and why it does not block SARS-CoV-2 completely. more ➔
LSP reports first closing of dementia fundEuropean life sciences investors LSP has closed a new fund to fight dementia at €50m. more ➔
Valneva in talks with EU about 60 million vaccine dosesFrench Valneva SE announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001. more ➔
Immunocore bags US$75m in Series C roundImmuno-oncology specialist Immunocore plc announced the completion of a $75m Series C private financing round. more ➔
EU approves second COVID-19 vaccineFollowing a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2. more ➔
